Migraines, often characterized by excruciating headache and nausea, can cause significant distress. They can cause people affected by them to lose an average of four to six days of work each year. Study authors say migraine sufferers who lack private health insurance are twice as likely to get inadequate treatment for their condition as their insured counterparts. Migraine patients insured through Medicaid are one and a half times as likely to receive substandard treatment.
“The tragedy is that we know how to treat this disabling condition. But because they are uninsured or inadequately insured, millions of Americans suffer needlessly,” said study author Rachel Nardin, MD, of Harvard Medical School and a member of the American Academy of Neurology. “Optimizing migraine care requires improvement in our health care systems as well as educating physicians to prescribe the best available drug and behavioral treatments.”
Neurologists usually recommend one of two types of drugs when a moderate-to-severe migraine strikes: “triptans” (such as sumatriptan) or dihydroergotamine. For the majority of people with migraine whose headaches are frequent or severe, neurologists also recommend a daily dose of one of several preventive medications. The researchers used these recommendations from the American Academy of Neurology to define standard migraine treatment.
For the study, the researchers analyzed data from two federal surveys, the National Hospital Ambulatory Medical Care Survey and the National Ambulatory Medical Care Survey, which provide a nationally representative sample of all US visits to doctors’ offices, hospital clinics and emergency rooms. They analyzed the 6,814 visits for migraine between 1997 and 2007.
The study found that people with no insurance were twice as likely to receive substandard migraine care as people with private health insurance. Medicaid enrollees were 50 percent more likely to receive substandard treatment, suggesting that “access to some forms of insurance is not the same as access to adequate care,” according to Nardin.
The uninsured and those on Medicaid were more likely to receive their migraine care in an emergency department than in a doctor’s office, which explained some, though not all, of their substandard care. People were one-fifth as likely to receive standard acute treatment to stop a migraine and 10 percent as likely to receive standard treatment to prevent migraine in emergency rooms than in doctor’s offices.
“This was a nationally representative sample of people, so our results give a comprehensive picture of migraine care in the entire US,” Nardin said. “With approximately 15 percent of the US population currently uninsured and migraine affecting 12 percent of the population, we estimate that 5.5 million Americans are at risk of substandard treatment of their migraines and of suffering and disability that could be avoided.”
The American Academy of Neurology, an association of more than 22,000 neurologists and neuroscience professionals, is dedicated to promoting the highest quality patient-centered neurologic care. A neurologist is a doctor with specialized training in diagnosing, treating and managing disorders of the brain and nervous system such as multiple sclerosis, restless legs syndrome, Alzheimer’s disease, narcolepsy and stroke.
Rachel L. Seroka | American Academy of Neurology
WAKE-UP provides new treatment option for stroke patients | International study led by UKE
17.05.2018 | Universitätsklinikum Hamburg-Eppendorf
First form of therapy for childhood dementia CLN2 developed
25.04.2018 | Universitätsklinikum Hamburg-Eppendorf
A research team led by physicists at the Technical University of Munich (TUM) has developed molecular nanoswitches that can be toggled between two structurally different states using an applied voltage. They can serve as the basis for a pioneering class of devices that could replace silicon-based components with organic molecules.
The development of new electronic technologies drives the incessant reduction of functional component sizes. In the context of an international collaborative...
At the LASYS 2018, from June 5th to 7th, the Laser Zentrum Hannover e.V. (LZH) will be showcasing processes for the laser material processing of tomorrow in hall 4 at stand 4E75. With blown bomb shells the LZH will present first results of a research project on civil security.
At this year's LASYS, the LZH will exhibit light-based processes such as cutting, welding, ablation and structuring as well as additive manufacturing for...
There are videos on the internet that can make one marvel at technology. For example, a smartphone is casually bent around the arm or a thin-film display is rolled in all directions and with almost every diameter. From the user's point of view, this looks fantastic. From a professional point of view, however, the question arises: Is that already possible?
At Display Week 2018, scientists from the Fraunhofer Institute for Applied Polymer Research IAP will be demonstrating today’s technological possibilities and...
So-called quantum many-body scars allow quantum systems to stay out of equilibrium much longer, explaining experiment | Study published in Nature Physics
Recently, researchers from Harvard and MIT succeeded in trapping a record 53 atoms and individually controlling their quantum state, realizing what is called a...
The historic first detection of gravitational waves from colliding black holes far outside our galaxy opened a new window to understanding the universe. A...
02.05.2018 | Event News
13.04.2018 | Event News
12.04.2018 | Event News
24.05.2018 | Ecology, The Environment and Conservation
24.05.2018 | Medical Engineering
24.05.2018 | Physics and Astronomy